26 Stock Top Picks and 3 ETF (Dec 7-13)
This week there were 26 Top Picks and 3 ETF in a wide range of industries: Consumer, Financials, Industrials, Basic Materials, Telecommunications, Energy, Healthcare, Technology and ETF.
He sold this a while ago and has now added it back. As a defensive stock it is one of the better plays over the next one or two years.. It has done a good job of re-vamping its stores and most of its capital spending is done. Buy 1 Hold 10 Sell 0…
Interesting things happening. New CEO with marketing sophistication trying to transform a business that's struggled since the IPO. Pretty good entry point. Strong brand. If you have the appetite for a small company, more speculative, good name to own.
He sold then when the US Dept. of Justice began investigating it. He bought it to get exposure to gold and emerging markets. Gold is now in focus, but he wouldn't buy a miner or revenue streams, but rather physical gold. Gold is at all-time highs, so buy in tranches.
It has a good presence in Quebec. They are interested in selling but he doesn't see who would buy them.
SLF vs. TD vs. CM All of the interest sensitives have been under pressure the last couple of months with rates rising.He favours TD. Tightly regulated oligopoly, and a levered play on the growth of the Canadian, and increasingly US, economy. Surplus of excess capital. 10x earnings. Dominant personal and commercial banking franchise. Good-sized banking…
TD vs. SLF vs. CM All of the interest sensitives have been under pressure the last couple of months with rates rising.He favours TD. Tightly regulated oligopoly, and a levered play on the growth of the Canadian, and increasingly US, economy. Surplus of excess capital. 10x earnings. Dominant personal and commercial banking franchise. Good-sized banking…
Owns shares of the company.Favorite USA large cap banking company.Regional banking crisis in the spring increased demand for products.Not worried about economy slowdown impacting bank.Reserves for loan losses have been set aside.Good time to buy with recent share price weakness.
(A Top Pick Dec 07/18, Up 66%) Nobody wanted to buy British stocks. Around 60% of Halma's revenues come outside the UK, so they're paid in other currencies as the pound falls--profits then rise. They make smoke alarms/detectors. Strong long-term potential, though no one has heard of it. Dividend is growing 17% annually. But earnings…
Growing revenues and earnings nicely, multiple going down at same time. 7-8x PE. Largest leasing company of new aircraft in the world. Profitable during pandemic, raised dividend each year. Taking advantage of supply chain chaos, enjoying upward pressure on lease rates. Debt-ridden airlines that can't buy, lease instead. Escalators in leasing agreements. Yield is 2.14%.…
It beat top and bottom lines last week but shares still sold off. They beat revenues and exceeded organic growth estimates. A great quarter.
Just sold it (down 49% this year). All the catalysts have gone: housing is slowing and rates are rising. He likes the company, but this will be dead money for a while. End demand isn't there.
🛢 Basic Materials
(A Top Pick Dec 07/18, Up 36%) A volatile stock, but he likes the golds, holding 10-20% in a portfolio. Gold has a long runway.
Good stalwart. Yield is over 6%, growing steadily at mid-single-digit pace. Dominant player in a needs, not wants, business. Sector is an oligopoly, well regulated. Peak of capex is behind it. Quite profitable. Strong investment-grade credit.
In the midst of a bidding war. More of a hold than a buy. Prospects for material upside are not very high. Better opportunities elsewhere. If you made profits, take some and invest in something like GEI or even TWM, if you have a higher risk tolerance.
(A Top Pick Sep 08/22, Down 7%) Likes the diversified business model. Leader. Decent valuation at 19x forward PE, with 12% earnings growth. Past year has seen a rotation out of managed care into more exciting pharma names. Stable revenues, downturn-resilient. Aging US demographics will benefit.
He's recemmended this before. They're hitting their stride. They announced today an acquisition in Florida which should be accretive to earnings and EBITDA. It's good, because PMH enters a new region. The stock will continue to grow by acquisition, then grow by organic growth by bringing their existing services and products to expand the market.…
(A Top Pick Mar 15/19, Down 24%) He still holds it in the portfolio, but had taken some out at $4 per share. He is looking to add to the cannabis sector again following the consolidation. He holds an $8.25 target. They are producing a CBD and THC beverage.
Diabetes is not going away. Obesity has made its latest drug popular. Have to ask what are the side effects? Trading at 34-35x forward PE, with a 25%+ growth rate. PEG of 1.6x is not cheap, but not expensive. Overbought. He'd like to see it at the 50- or 200-day MA, around $170-175.
Sideways chart which has a history of wide swings. It could now roll over, but is breaking above old highs. Tough to call this. It could continue breaking out. If it breaks above $55 and holds, then sell.
MSFT vs. GOOG in terms of AI Though MSFT is up 32% this year vs. GOOG's 49%, he prefers MSFT, because Google fumbled their AI roll-out while MSFT will benefit more from AI, as offered in their suite of services and how it benefits their consumers. Both companies are strong with strong user bases and…
(A Top Pick Dec 14/18, Up 109%) Makers of screen technology out of Idaho. Their technology shortened the width of the screen, which allowed manufacturers to add more technology in the same phone body. He sold out at $207. It will give another opportunity to buy in, but there is more competition coming.
(A Top Pick Oct 11/22, Up 54%) It is involved in the AI space and has been integrating it into their product solutions. It has done well with the tech bounce. He could see a further pullback before getting back into it.
(A Top Pick Dec 12/18, Up 15%) Linked to the UN Sustainable Goal: educational, healthcare, food, sanitation companies. Lots of exposure to emerging markets with only 35% US exposure. This will do well along with the world ex-US.
(A Top Pick Dec 12/18, Up 17%) An ETF that tracks the S&P minus fossil fuels and weapons. Strongly correlates the S&P with slight outperformance. You get market returns and do good.
If you have cash to invest, consider buy this and not any old staple. There's now a decent yield on a 30-day.